These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24380762)

  • 41. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
    Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
    J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human parainfluenza virus type 2 V protein inhibits and antagonizes tetherin.
    Ohta K; Goto H; Yumine N; Nishio M
    J Gen Virol; 2016 Mar; 97(3):561-570. PubMed ID: 26675672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adaptive mutations of neuraminidase stalk truncation and deglycosylation confer enhanced pathogenicity of influenza A viruses.
    Park S; Il Kim J; Lee I; Bae JY; Yoo K; Nam M; Kim J; Sook Park M; Song KJ; Song JW; Kee SH; Park MS
    Sci Rep; 2017 Sep; 7(1):10928. PubMed ID: 28883554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells.
    Jolly C; Booth NJ; Neil SJ
    J Virol; 2010 Dec; 84(23):12185-99. PubMed ID: 20861257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The viral protein U (Vpu)-interacting host protein ATP6V0C down-regulates cell-surface expression of tetherin and thereby contributes to HIV-1 release.
    Waheed AA; Swiderski M; Khan A; Gitzen A; Majadly A; Freed EO
    J Biol Chem; 2020 May; 295(21):7327-7340. PubMed ID: 32291285
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression.
    Dotson D; Woodruff EA; Villalta F; Dong X
    J Biol Chem; 2016 Feb; 291(8):4236-46. PubMed ID: 26742839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin.
    Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Vpu-interacting Protein SGTA Regulates Expression of a Non-glycosylated Tetherin Species.
    Waheed AA; MacDonald S; Khan M; Mounts M; Swiderski M; Xu Y; Ye Y; Freed EO
    Sci Rep; 2016 Apr; 6():24934. PubMed ID: 27103333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of calcium-modulating cyclophilin ligand on human immunodeficiency virus type 1 particle release and cell surface expression of tetherin.
    Bego MG; Dubé M; Mercier J; Cohen EA
    J Virol; 2009 Dec; 83(24):13032-6. PubMed ID: 19793820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations in the Neuraminidase-Like Protein of Bat Influenza H18N11 Virus Enhance Virus Replication in Mammalian Cells, Mice, and Ferrets.
    Zhong G; Fan S; Hatta M; Nakatsu S; Walters KB; Lopes TJS; Wang JI; Ozawa M; Karasin A; Li Y; Tong S; Donis RO; Neumann G; Kawaoka Y
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced pathogenicity and neurotropism of mouse-adapted H10N7 influenza virus are mediated by novel PB2 and NA mutations.
    Zhang X; Xu G; Wang C; Jiang M; Gao W; Wang M; Sun H; Sun Y; Chang KC; Liu J; Pu J
    J Gen Virol; 2017 Jun; 98(6):1185-1195. PubMed ID: 28597818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The size and conservation of a coiled-coil structure in the ectodomain of human BST-2/tetherin is dispensable for inhibition of HIV-1 virion release.
    Andrew AJ; Berndsen CE; Kao S; Strebel K
    J Biol Chem; 2012 Dec; 287(53):44278-88. PubMed ID: 23152502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Counteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu gene.
    Nikovics K; Dazza MC; Ekwalanga M; Mammano F; Clavel F; Saragosti S
    PLoS One; 2012; 7(4):e35411. PubMed ID: 22530020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.
    Heusinger E; Deppe K; Sette P; Krapp C; Kmiec D; Kluge SF; Marx PA; Apetrei C; Kirchhoff F; Sauter D
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
    Abed Y; Baz M; Boivin G
    Antivir Ther; 2006; 11(8):971-6. PubMed ID: 17302366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice.
    Solorzano A; Zheng H; Fodor E; Brownlee GG; Palese P; García-Sastre A
    J Gen Virol; 2000 Mar; 81(Pt 3):737-42. PubMed ID: 10675411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus.
    Kiso M; Ozawa M; Le MT; Imai H; Takahashi K; Kakugawa S; Noda T; Horimoto T; Kawaoka Y
    J Virol; 2011 May; 85(10):4667-72. PubMed ID: 21367898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The C-Terminal End of HIV-1 Vpu Has a Clade-Specific Determinant That Antagonizes BST-2 and Facilitates Virion Release.
    Sharma S; Jafari M; Bangar A; William K; Guatelli J; Lewinski MK
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.